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ABSTRACT
Cryptococcal meningitis is a central nervous system infection cause by Cryptococcus neoformans. Although Cryp-
tococcus is found in bird droppings, it has never been reported for those ranchers involved in the niche swiftlet 
ranching industry despite having close proximity with the bird droppings. We present here a case of a 41-year-old 
healthy swiftlet rancher who presents with a history of prolonged fever, headache and altered behaviour of a month 
duration. Cerebral spinal fluid analysis revealed the presence of Cryptococcus. He was treated with intravenous am-
photericin B and flucytosine and discharged well with fluconazole consolidation therapy for 8 weeks, followed by 
maintenance therapy for 1 year. We believe this is the first reported case of Cryptococcal meningitis (CM) occurring 
in an immunocompetent swiftlet rancher. This case should highlight the needs to wear a proper personal protective 
equipment inside a swiftlet ranch due to the constant exposure to the potential cryptococcal-rich environment. A 
high index of suspicion, careful history taking and physical examination focusing on neurologic assessment is key to 
early diagnosis and timely management of CM. 
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INTRODUCTION
Cryptococcus neoformans is an encapsulated yeast-like 
fungus. that has a worldwide distribution. In 1950s, 
there were less than 300 reported cases but nowadays it 
was estimated that there are more than a million cases 
of cryptococcal infections worldwide. Cryptococcus 
has been recently classified into seven different 
species (1). The two most prominent species were C. 
neoformans and C. gattii. C. neoformans is found in 
soil contaminated with bird droppings and affects 
immunocompromised hosts with a typical background 
history of prolonged steroid usage, hematologic 
malignancies, solid-organ transplantation, diabetes 
mellitus, or human immunodeficiency virus (HIV) 
infection while C. gatti was found in eucalyptus trees 
in tropical or subtropical regions, which usually cause 
infection in the immunocompetent hosts.
CASE REPORT
Mr N, 41-year-old man with no known co-morbidities 
presented with intermittent fever, frontal headache, and 
altered behaviour for one-month duration. There were 
no constitutional or raised intracranial pressure (ICP) 
symptoms. He was initially diagnosed as having sinusitis 
after a computed tomography (CT) scan of the brain 
revealed evidence of sinusitis with no other abnormality 
detected. However, his symptoms did not subside with 
the prescribed treatment and he sought medical advice 
again after 3 weeks has lapsed. On further probing, 
he was found to be a full-time swiftlet rancher who 
frequently visits swiftlet ranches for harvesting edible 
bird nests and cleaning the bird droppings. Upon his 
second admission, he was appeared to be confused 
with no other neurological signs documented. Systemic 
examination was unremarkable.
His initial full blood count was within normal limits. Full 
blood picture revealed neutrophillia with no abnormal 
cells seen. Serum creatinine level and liver function 
test were normal. Fasting blood sugar was 5.6 and het 
was not known to have diabetes mellitus. Urinalysis 
result was normal. HIV, treponema antibodies, hepatitis 
C virus antibody and hepatitis B surface antigen were 
not reactive. Serology for Mycoplasma pneumonia, 
Salmonella paratyphi, Salmonella typhi, rickettsial 
antibodies OX 19 and OXK, Dengue virus NS 1 
antigen were all negatives. Blood and urine culture and 
sensitivities have no significant growth. However, his 
erythrocyte sedimentation rate was noted to be elevated 
at 33 mm/h. C- reactive protein was 1.5mg/L. Chest 
X-ray was reported as normal. Lumbar puncture (LP) 
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was performed and cerebral spinal fluid analysis (CSF) 
showed the presence of red blood cell at 175/uL (likely 
due to traumatic tap), low glucose level, high protein level 
(Table 1) with Cryptococcus seen in India ink staining 
(Figure 1). Opening pressure of CSF was not documented. 
No CSF fungal culture or cryptococcal antigen titre was 
sent due to the lack of laboratory facility at the referring 
hospital. His confusion state resolved immediately after 
LP. A diagnosis of cryptococcal meningitis (CM) was 
made and he was started on intravenous amphotericin 
B deoxycholate (AmBd) and flucytosin therapy. Patient 
was then referred to our centre for continuation of 
treatment due to financial constraint.
Upon presentation to our centre, he was orientated to 
time, place and person. Neurological and fundoscopy 
examination were unremarkable. Patient was treated 
with IV Amphotericin B 50mg OD (0.7mg/kg/day) and 
tablet Flucytosine 1500mg QID (100 mg/kg/day in 4 
divided doses). He was to complete IV Amphotericin B 
plus flucytosine for total of 2 weeks duration followed 
by consolidate therapy with fluconazole 400mg BD 
for 8 weeks duration and maintenance therapy with 
fluconazole 200mg OD for another 6-12 months. A 
repeated LP on day 7 of treatment revealed clearing of 
the CSF (Table I). However, two months later, the 
patient was readmitted with severe frontal headache for 
a week duration. No neurological deficit was identified. 
Repeated contrasted CT scan of the brain was normal 
and a third LP was performed (Table I). Cryptococcal 
antigen latex agglutination titre (Cryptococcus Antigen 
Latex Agglutination Test System, IMMY) in CSF was 1:8, 
indicating a high likelihood of satisfactory response with 
the prescribed antifungal treatment. Patient remained 
well during clinic review and switched to maintenance 
therapy for one-year duration.  
DISCUSSION
C.neoformans is the commonest cause of fungal 
meningitis worldwide and 4th most common 
Figure  1 :  Cryptococcus seen in India Ink stain
Table I: Serial CSF findings
CSF finding 30/8/17 8/9/17 17/10/17
Appearance Clear Clear Clear
RBC/uL 175 0 0
WBC (<10 cells/iu) 0 10 (neutrophil) 30 (lymphocytes)
Protein (0.1-0.45)g/L 2.45 2.74 1.95
Glucose (2.2-4.2) mmol/l 0.2 0.4 1.1
Indian ink Cryptococcus seen Negative Negative
Gram stained smear No bacteria No bacteria No bacteria
Acid fast bacilli (AFB) smear No AFB No AFB No AFB
Globulin Positive Negative Positive
Culture No growth No growth No growth
Opening pressure - 18cmH
2
O 5cm H
2
O
opportunistic infection in patients with HIV. It typically 
infects immunocompromised patients. CM is easily 
diagnosed by LP and CSF analysis including cell counts, 
biochemistry, protein, glucose, Indian ink staining (75-
85% sensitive), fungal culture or cryptococcal latex 
agglutination assay (95% sensitive). Serum cryptococcal 
latex agglutination test has 87% sensitive in HIV-negative 
patients (2). CT or magnetic resonance imaging of the 
brain is mandatory prior to LP procedure to exclude 
the presence of hydrocephalus as this can be a sign of 
increase ICP. Typically, CSF analysis will reveal low 
glucose and high protein levels, a finding similar to ours 
(3). Although Cryptococcus antigen titre was not sent 
initially, a repeated LP revealed a titre of 1:8 which may 
imply that the patient is responding satisfactory to the 
prescribed treatment. Unfortunately, the repeated CSF 
cultures were negative, a factor which may be attributed 
by insufficient CSF samplings or the samples may not 
have undergone the necessary centrifugation process to 
increase the yield rate. Furthermore, the cultures were 
not specifically cultured for fungus.
To date, there is very little known about the pathogenesis 
and natural progression of CM in an immunocompetent 
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There is limitation of our case report. Firstly, we are not 
able to confirm the presence of cryptococcus inside a 
swiftlet ranch as the permission to take samples was not 
granted.
CONCLUSION
CM is a rare disease in immunocompetent patients. We 
believe this is the first reported case of CM occurring 
in a healthy swiftlet rancher. This case should highlight 
the needs to wear proper personal protective equipment 
inside a swiftlet ranch due to the constant exposure to 
the potential cryptococcal-rich environment. However, 
more studies need to be carried out to study the presence 
of Cryptococcus in work environment and to ascertain 
its direct relationship. A careful history and physical 
examination focusing on neurologic assessment with a 
high index of suspicion in patients with known exposure 
is key to early diagnosis and timely management of CM.
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host. It is important to rule out undiagnosed diabetes 
in CM as hyperglycemia can impair host defence 
mechanism. Our patient is fit swiftlet rancher who 
has frequent exposure to bird droppings. His initial 
presentation of fever and headache with negative 
neurological findings has not prompted the diagnosis 
of CM as CM has not been reported those working in 
the swiftlet ranching before. In our case report, we are 
unable to prove that CM was directly cause by exposing 
to cryptococcal-rich work environment as fungal culture 
of the workplace was not performed. Nevertheless, 
harmless fungal contamination with Aspergillus sp., 
Candida sp., Cladosporium sp., Neurospora sp., and 
Penicillum sp. is known to be present in raw cleaned 
edible bird nest (EBN). Swiftlets, the birds that produce 
EBN are non-migratory and do not share flying or 
nesting space with other species of birds. Hence their 
chance of contracting the avian virus is minimal (4). 
Transmission of Cryptococcus infection from swiftlets 
to human has not been documented despite the close 
human encounters to the human kinds. 
Many swiftlet ranchers manage the farm without proper 
personal protective equipment that could protect them 
from fungal or bacterial infections. We postulate that 
chronic exposure to cryptococcal- rich environment 
could predispose a healthy person to acquire 
cryptococcal infection but further study need to be 
perform to confirm the actual presence of cryptococcus 
inside the swiftlet ranches.
Combination of amphotericin B deoxycholate plus 
flucytosine is the most effective fungicidal regimen in 
cryptococcal infection. CSF Cryptococci clearance was 
significantly faster with amphotericin B deoxycholate 
and flucytosine combination comparing with 
amphotericin B deoxycholate alone, amphotericin B 
deoxycholate plus fluconazole, and triple-drug therapy. 
Hence, current induction therapy for CM in non-HIV 
infected and non-transplant patient is amphotericin 
B deoxycholate (0.7–1.0 mg/kg/day) plus flucytosine 
(100 mg/kg/day) for 4weeks, which may be extended 
to 6weeks if neurological complications are present. 
Unfortunately, there is no clear treatment consensus for 
length of induction therapy in immunocompetent group 
of patients with cryptococcal infection (5).
